Other Species / Isoforms
  CD3D (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
N74
PRGIYRCNGTDIYkD
0 1
CD3D (human) PRGIYRCNGTDIYkD N74
CD3D (mouse) PRGIYLCnGTEQLAK N74-ng
CD3D (rat) PRGMYMCNGTEELAK N74
K80-ub
CNGTDIYkDkESTVQ
0 2
CD3D (human) CNGTDIYkDkESTVQ K80-ub
CD3D (mouse) CnGTEQLAKVVSSVQ A80
CD3D (rat) CNGTEELAKEVSTVQ A80
K82-ub
GTDIYkDkESTVQVH
0 1
CD3D (human) GTDIYkDkESTVQVH K82-ub
CD3D (mouse) GTEQLAKVVSSVQVH V82
CD3D (rat) GTEELAKEVSTVQVY E82
T139-p
RLSGAADtQALLRND
0 26
CD3D (human) RLSGAADtQALLRND T139-p
CD3D (mouse) RPSGAAEVQALLKNE V139
CD3D (rat) RLSGAVDTQVLLKNE T139
Y149-p
LLRNDQVyQPLRDRD
Upstream
0 372
Treatment
  • anti-CD28
  • anti-CD3
  • U0126
CD3D (human) LLRNDQVyQPLRDRD Y149-p
CD3D (mouse) LLKNEQLyQPLRDRE Y149-p
CD3D (rat) LLKNEQLYQPLRDRD Y149
Y160-p
RDRDDAQysHLGGNW
Upstream
0 325
Treatment
  • anti-CD28
  • anti-CD3
  • U0126
CD3D (human) RDRDDAQysHLGGNW Y160-p
CD3D (mouse) RDREDTQYSRLGGNW Y160
CD3D (rat) RDRDDAQYSRLGGNW Y160
S161-p
DRDDAQysHLGGNWA
0 117
CD3D (human) DRDDAQysHLGGNWA S161-p
CD3D (mouse) DREDTQYSRLGGNWP S161
CD3D (rat) DRDDAQYSRLGGNWP S161